title: Effects of basal insulin application on serum visfatin and adiponectin levels in type 2 diabetes.
abstract: The aim of this study was to investigate the effects of basal insulin application on the serum visfatin and adiponectin (APN) levels of patients with type 2 diabetes mellitus (T2DM). A total of 200 patients with T2DM, who were diagnosed in The Third People's Hospital of Jinan (glycosylated hemoglobin ≥7%), were randomly divided into treatment and control groups. The patients used only oral hypoglycemic drugs and had never received insulin therapy. In the treatment group, basal insulin was administered in combination with the original application of oral hypoglycemic drugs, whereas the control group maintained the original use of oral hypoglycemic drugs or took other oral hypoglycemic agents. The body mass index and fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, visfatin, APN and blood lipid levels of the patients were examined prior to the treatment and six months later. The drug and insulin doses in the treatment group were adjusted according to the patients' blood glucose, which allowed the fasting and postprandial blood glucose levels to attain the standards. The fasting and postprandial blood glucose levels in the control group also achieved the standards. It was found that the six-month application of basal insulin could significantly decrease the glycosylated hemoglobin and significantly increase the serum APN levels; the serum visfatin levels, however, remained unchanged. The immediate application of basal insulin could facilitate the attainment of glycosylated hemoglobin standards in T2DM and could increase the plasma APN levels, preventing diabetic vascular complications.
authors.affiliation: Department of Endocrinology, The Third People's Hospital of Jinan, Jinan, Shandong 250132, P.R. China.
authors.forename: Wei-Dong
authors.initials: WD
authors.lastname: Wang
authors.affiliation: Department of Endocrinology, The Third People's Hospital of Jinan, Jinan, Shandong 250132, P.R. China.
authors.forename: Lin
authors.initials: L
authors.lastname: Xing
authors.affiliation: Department of Clinical Laboratory, The Third People's Hospital of Jinan, Jinan, Shandong 250132, P.R. China.
authors.forename: Jun-Ru
authors.initials: JR
authors.lastname: Teng
authors.affiliation: Department of Endocrinology, The Third People's Hospital of Jinan, Jinan, Shandong 250132, P.R. China.
authors.forename: Shuo
authors.initials: S
authors.lastname: Li
authors.affiliation: Department of Endocrinology, The Third People's Hospital of Jinan, Jinan, Shandong 250132, P.R. China.
authors.forename: N A
authors.initials: NA
authors.lastname: Mi
keywords: basal insulin; complications; type 2 diabetes